Skip to main content
Fig. 1 | BMC Immunology

Fig. 1

From: Low-dose interleukin-2 can improve salivary secretion but not lymphocyte infiltration of salivary glands in a murine model of Sjögren’s syndrome

Fig. 1

Low-dose IL-2 can improve salivary secretion in a Sjögren’s syndrome model. a Experimental schema of IL-2 treatment: Mice were injected subcutaneously with IL-2, once daily for the first 6 days, and every 4 days for the subsequent maintenance treatment. The mice in the short-course and long- course group group were sacrificed at the age of 9 weeks and 23 weeks respectively (n = 5). b and c Changes in body weight parameters of b short-course group and c long-course group(n = 5). d Changes in salivary flow rate per unit body weight of mice treated with IL-2 (μl/g) (n = 5)

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us